|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
*
From the Department of Thoracic Surgery (Drs. Bonnette and Puyo) and the Department of Statistics (Dr. Gabriel), Hôpital Foch, Suresnes, France; the Department of Thoracic Surgery (Dr. Giudicelli), Hôpital Ste-Marguerite, Marseille, France; the Department of Thoracic Surgery (Dr. Regnard), Hôpital Marie Lannelongue, Le Plessis-Robinson, France; the Department of Thoracic Surgery (Dr. Riquet), Hôpital Laënnec, Paris, France; and the Department of Thoracic Surgery (Dr. Brichon), Hôpital La Tronche, Grenoble, France.
A complete list of Groupe Thorax investigators and participating
centers is located in the Appendix.
Correspondence to: Pierre Bonnette, MD, Service de Chirurgie Thoracique, Hôpital Foch, BP 36, 40 rue Worth, 92151 Suresnes, France; e-mail: pierre.bonnette{at}wanadoo.fr
Objectives: Published series on the synchronous combined resection of brain metastases and primary non-small cell lung cancer are small and scarce. We therefore undertook a multicenter retrospective study to determine long-term survival and identify potential prognostic factors.
Design: Our series includes 103 patients who were operated on between 1985 and 1998 for the following tumors: adenocarcinomas (74); squamous cell carcinomas (20); and large cell carcinomas (9). Three patients had two brain metastases, and one patient had three metastases; the remaining patients had a single metastasis. Ninety-three patients presented with neurologic signs that regressed completely after resection in 60 patients and partially, in 26 patients. Neurosurgical resection was incomplete in six patients. Seventy-five patients received postoperative brain radiotherapy. The time interval between the brain operation and the lung resection was < 4 months. Pulmonary resection was incomplete in eight patients.
Results: The survival calculated from the date of the first operation was 56% at 1 year, 28% at 2 years, and 11% at 5 years. Univariate analysis showed a better prognosis for adenocarcinomas (p = 0.019) and a trend toward a better prognosis for patients with small pulmonary tumors (T1 vs T3, p = 0.068), N0 stage disease (N0 vs N+, p = 0.069), and complete pulmonary resection (p = 0.057). In a multivariate analysis, adenocarcinoma histology also affected the survival rate (p = 0.03).
Conclusions: It seems legitimate to proceed with lung resection after complete resection of a single brain metastasis, at least in patients with an adenocarcinoma and a small lung tumor and without abnormal mediastinal lymph nodes seen on the CT scan or during mediastinoscopy.
Key Words: brain neoplasms lung neoplasms neoplasm metastasis neurosurgery survival rate thoracic surgery
This article has been cited by other articles:
![]() |
J. Furak, I. Trojan, T. Szoke, L. Agocs, A. Csekeo, J. Kas, E. Svastics, J. Eller, and L. Tiszlavicz Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems Ann. Thorac. Surg., January 1, 2005; 79(1): 241 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Getman, E. Devyatko, D. Dunkler, F. Eckersberger, A. End, W. Klepetko, G. Marta, and M. R. Mueller Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353. [Full Text] [PDF] |
||||
![]() |
M. Paci, G. Sgarbi, G. Ferrari, S. De Franco, and V. Annessi Controversies Over UICC-TNM Classification of Non-small Cell Lung Cancer : Model for a Diagnostic Path Chest, August 1, 2002; 122(2): 754 - 754. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |